JAK2-V617F activates β1-integrin-mediated adhesion of granulocytes to vascular cell adhesion molecule 1

Leukemia. 2017 May;31(5):1223-1226. doi: 10.1038/leu.2017.26. Epub 2017 Jan 18.

Authors

N Gupta¹, B Edelmann¹, T M Schnoeder^{1

2}, F C Saalfeld¹, D Wolleschak¹, S Kliche³, B Schraven³, F H Heidel^{1

2}, T Fischer¹

Affiliations

¹ Department of Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany.
² Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Germany.
³ Institute of Molecular and Clinical Immunology, Otto-von-Guericke University, Magdeburg, Germany.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cell Adhesion / physiology*
Chronic Disease
Granulocytes / pathology*
Humans
Integrin beta1 / physiology*
Janus Kinase 2 / metabolism*
Myeloproliferative Disorders / enzymology
Myeloproliferative Disorders / metabolism
Myeloproliferative Disorders / pathology*
Vascular Cell Adhesion Molecule-1 / metabolism*

Substances

Integrin beta1
Vascular Cell Adhesion Molecule-1
JAK2 protein, human
Janus Kinase 2